Sign in Request a demo

Real Pharma Problems. Real Solutions.

Every engagement starts with a business problem, not a technology discussion. Here are representative examples of the challenges our clients bring to us.

Use Cases

Commercial Intelligence

Challenge: Missed a competitor's ASCO readout — found out 3 days later from a sales rep.

A brand team in a competitive oncology indication discovered a significant competitor data presentation at ASCO three days after it happened, from a field rep. Their CI process relied on manual abstract screening and post-conference vendor reports.

Solution: IntelXion™ conference monitoring. Pre-ASCO abstract screening flagged 34 relevant submissions from 2,400+ total. Post-conference competitive summary delivered within 48 hours, with full pipeline implications and suggested messaging responses.

Outcome: Brand team pivoted messaging strategy before competitors' reps could react. Leadership cited it as the fastest competitive response in company history.

Incentive Compensation

Challenge: 15% of rep time lost to IC disputes — a 200-rep specialty pharma company.

The IC operations team was spending two full days per cycle on payout disputes. Error rate in the manual process was 12%. Reps were building shadow spreadsheets and regularly calling the IC helpdesk.

Solution: COMPXION™ automated payout calculation with full data lineage. COMPXION CLARI™ self-service portal giving reps instant plain-English explanations with full calculation breakdown traceable to source data.

Outcome: Error rate dropped to under 1%. Dispute resolution time from 2 days to 4 hours. Rep IC satisfaction scores improved 22 points in the next field survey.

Sales Force Effectiveness

Challenge: 89 high-potential HCPs in the territory had never been contacted.

A commercial analytics review revealed the field team was over-calling familiar physicians while a significant number of high-potential HCPs — who matched the profile of their best prescribers — had never been contacted.

Solution: Lookalike modeling using Rx data, claims and specialty filters identified white-space targets. Updated call plan pushed directly to Veeva CRM mid-cycle.

Outcome: 23% increase in new HCP reach within one sales cycle. 11 of the 89 white-space HCPs became new prescribers within the quarter.

Patient Analytics

Challenge: Patients dropping between diagnosis and first prescription — no visibility why.

Brand leadership knew their time-to-therapy was longer than benchmarks but had no data showing where in the journey the problem was occurring or why.

Solution: PatientXion™ claims-based journey mapping identified three distinct drop-off points: prior authorization burden, hub enrollment delay, and copay barrier at first fill. Each had a different root cause and required a different field response.

Outcome: Field force re-aligned around PA support and co-pay program promotion. Time-to-therapy improved by 11 days. 90-day PDC improved by 0.06 in one quarter.

Market Access

Challenge: Formulary wins at three major payers not converting to prescription growth.

A brand had secured Tier 2 coverage at three large commercial payers but saw no corresponding Rx lift in those covered territories.

Solution: Pull-through analytics linked formulary wins to rep call activity and Rx data. Analysis showed the field force was calling the same high-prescribing physicians rather than shifting focus to newly covered territories.

Outcome: 18% improvement in pull-through in priority markets within one quarter.

Forecasting & Launch

Challenge: No agreed KPIs for the first 12 weeks of a first-in-class oncology launch.

A brand team had no framework for tracking launch performance in the critical early weeks and no mechanism for identifying territory-level underperformance before it became a gap.

Solution: Launch velocity scorecard with Week 4, Week 8 and Week 12 leading indicators — new prescriber ramp, formulary coverage, share of voice and patient initiation signals — compared against analogue launches.

Outcome: Territory-level risks identified 8 weeks before they would have appeared in standard sales reporting. Three regions course-corrected before quarter end.